共 21 条
[1]
Dropcho EJ(2005)Update on paraneoplastic syndromes Curr Opin Neurol 18 331-336
[2]
Shams’ili S(2003)Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients Brain 126 1409-1418
[3]
Grefkens J(2004)Immunomodulatory treatment trial for paraneoplastic neurological disorders Neuro Oncol 6 55-62
[4]
de Leeuw B(2006)Rituximab, an Anti-CD20 monoclonal antibody: history and mechanism of action Am J Transplant 6 859-866
[5]
Vernino S(1997)International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. The ataxia neuropharmacology Committee of the World Federation of Neurology J Neurol Sci 145 205-211
[6]
O’Neill BP(2004)Recommended diagnostic criteria for paraneoplastic neurological syndromes J Neurol Neurosurg Psychiatry 75 1135-1140
[7]
Marks RS(2002)Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy J Neurol 249 745-753
[8]
Pescovitz MD(2006)An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes J Neurol 253 16-20
[9]
Trouillas P(2006)B cells in the pathophysiology of autoimmune neurological disorders: A credible therapeutic target Pharmacol Ther 112 57-70
[10]
Takayanagi T(undefined)undefined undefined undefined undefined-undefined